Paris, France

Helene Guillard

USPTO Granted Patents = 3 


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2013-2017

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Celebrating Innovation: Helene Guillard, A Trailblazing Inventor from Paris

Introduction: Helene Guillard is a distinguished inventor based in Paris, France, who has made significant contributions to the field of pharmaceuticals. With a total of three patents to her name, her innovative spirit and dedication have positioned her as a key player in the industry.

Latest Patents: Among her most notable inventions are the ulipristal acetate tablets. These pharmaceutical tablets are designed for oral administration and include ulipristal acetate combined with various excipients. The formulation details include at least one diluent making up 50 to 98.5 wt %, at least one binding agent comprising 0 to 10 wt %, at least one disintegrating agent in an amount of 0.5 to 10 wt %, and at least one lubricant in the range of 0 to 10 wt %. Her work on these tablets demonstrates her commitment to advancing medical treatment options.

Career Highlights: Helene Guillard is currently associated with Laboratoire HRA-Pharma, where she continues to drive advancements in pharmaceutical innovation. Her focus on creating effective medicinal products has been invaluable to the company and the wider healthcare community.

Collaborations: Throughout her career, Helene has worked alongside talented colleagues such as Erin Gainer and Denis Gicquel. These collaborations have allowed her to enhance her research and development endeavors, foster innovation, and contribute to the success of their collective projects.

Conclusion: Helene Guillard exemplifies the essence of innovation in the pharmaceutical sector. Her dedication to creating effective treatment solutions, such as ulipristal acetate tablets, showcases her influence as an inventor. As she continues her work at Laboratoire HRA-Pharma, she remains an inspiring figure for aspiring inventors and the pharmaceutical industry alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…